| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |